Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis
Recruiting now
Conditions studied: Prostate Cancer, Organoid
In brief
This project plans to establish an organoid chip model of prostate cancer patients with internal organ metastasis from surgical or biopsy tissue sources, and test the sensitivity of commonly used chemotherapy drugs based on organoid chip drug sensitivity testing technology to screen out sensitive individualized treatment plans.
Key facts
- Study ID
- NCT06536725
- Run by
- Tianjin Medical University Second Hospital
- People needed
- 35
- Starts
- 2024-06-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2024-08-05
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Patients with visceral metastasis of prostate cancer diagnosed clinically or pathologically;
- Age ≥ 18 years old;
- ECOG score ≤ 2 points or ECOG score 3-4 points due to tumor progression;
- Normal liver and kidney function, serum transaminase ALT<66 U/L, AST<36 U/L, total bilirubin<22 umol/L, creatinine<106 umol/L, urea nitrogen<6.1 mmol/L; Normal bone marrow function: neutrophil count ≥ 1800/mm3 and platelet count ≥ 100000/mm3;
- Can obtain surgical or biopsy samples;
- Patients voluntarily join this study and sign an informed consent form.
You may not qualify if…
- Patients with severe heart, liver, kidney, and peripheral nervous system diseases, as well as autoimmune diseases such as hyperthyroidism and hypothyroidism; Systemic lupus erythematosus, etc;
- Patients who are unable to obtain tissue samples;
- Subjects with active pulmonary tuberculosis (TB);
- Subjects who are preparing for or have previously undergone tissue/organ transplantation;
- Exclusion criteria are not listed, but the researchers believe that patients who are not suitable to participate in this clinical study.
Where it is running
- Tianjin Medical Unversity Second Hospital — Tianjin, Tianjin Municipality, China (enrolling)
- Tianjin Medical Unversity Second Hospital — Tianjin, Tianjin Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.